Pedro Mendes-Ferreira

UnIC@RISE, University of Porto

Affiliated withUniversity of Porto

Research Area

Biography

Pedro Mendes-Ferreira has not added Biography.
If you are Pedro Mendes-Ferreira and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 1	2023

Other Publications

Article	Year
Therapeutic potential of neuregulin-1 in cardiovascular disease. Drug discovery today\| PubMed ID: 23384772	2013
Myocardial and anti-inflammatory effects of chronic bosentan therapy in monocrotaline-induced pulmonary hypertension. Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology\| PubMed ID: 24780128	2014
Angiotensin-(1-7) modulates angiotensin II-induced vasoconstriction in human mammary artery. Cardiovascular drugs and therapy\| PubMed ID: 25301384	2014
Neuregulin-1 improves right ventricular function and attenuates experimental pulmonary arterial hypertension. Cardiovascular research\| PubMed ID: 26503987	2016
Pulmonary arterial hypertension: Basic knowledge for clinicians. Archives of cardiovascular diseases\| PubMed ID: 27595464	2016
Improvement in left intraventricular pressure gradients after aortic valve replacement in aortic stenosis patients. Experimental physiology\| PubMed ID: 28194824	2017
Loss of KCNK3 is a hallmark of RV hypertrophy/dysfunction associated with pulmonary hypertension. Cardiovascular research\| PubMed ID: 29360952	2018
Urocortin-2 improves right ventricular function and attenuates pulmonary arterial hypertension. Cardiovascular research\| PubMed ID: 29584808	2018
Neuregulin-1 attenuates right ventricular diastolic stiffness in experimental pulmonary hypertension. Clinical and experimental pharmacology & physiology\| PubMed ID: 30339273	2019
Bmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Arterial Hypertension. Circulation\| PubMed ID: 30586714	2019
The effect of different anaesthetics on echocardiographic evaluation of diastolic dysfunction in a heart failure with preserved ejection fraction model. Scientific reports\| PubMed ID: 32973263	2020
Efficacy of the thromboxane receptor antagonist NTP42 alone, or in combination with sildenafil, in the sugen/hypoxia-induced model of pulmonary arterial hypertension. European journal of pharmacology\| PubMed ID: 33121950	2020
Kcnk3 dysfunction exaggerates the development of pulmonary hypertension induced by left ventricular pressure overload. Cardiovascular research\| PubMed ID: 33483721	2021
Iron Deficiency in Pulmonary Arterial Hypertension: A Deep Dive into the Mechanisms. Cells\| PubMed ID: 33672218	2021
The adult heart requires baseline expression of the transcription factor Hand2 to withstand right ventricular pressure overload. Cardiovascular research\| PubMed ID: 34550326	2022
Cardiac and Pulmonary Vascular Dysfunction in Vitamin D-Deficient -Mutant Rats. American journal of respiratory cell and molecular biology\| PubMed ID: 36047774	2022
The thromboxane receptor antagonist promotes beneficial adaptation and preserves cardiac function in experimental models of right heart overload. Frontiers in cardiovascular medicine\| PubMed ID: 36588576	2022
Human-umbilical cord matrix mesenchymal cells improved left ventricular contractility independently of infarct size in swine myocardial infarction with reperfusion. Frontiers in cardiovascular medicine\| PubMed ID: 37342444	2023